Frank Rondel
After months of anticipation, the Trump administration officially launched TrumpRx, a new platform offering cash discounts on brand-name prescription medications, on Thursday, providing Americans with a new way to reduce their out-of-pocket costs, reports customreceipt.com, via original press release TrumpRx. At the launch event held in the South Court Auditorium of the White House, President Donald Trump described the initiative as a major step in making healthcare more affordable for U.S. citizens, emphasizing that the program is intended to provide significant savings for those paying directly for medications rather than using insurance.
TrumpRx was designed in response to the consistently higher costs Americans face for brand-name medications compared with other developed nations, despite much of the drug development research being funded in part by federal grants. Throughout his political career, Trump has repeatedly highlighted the need for Washington to influence drug pricing, advocating for policies such as Medicare price negotiations and the “most favored nation” plan from his first term. While the original plan was blocked by federal courts, Trump revisited these efforts after returning to office, issuing an executive order encouraging pharmaceutical companies to lower prices voluntarily under the threat of regulatory measures. According to the White House, this resulted in 16 agreements with major drug manufacturers, including exemptions from certain tariffs in exchange for price reductions for Medicaid patients and future drugs being launched at “most favored nation” rates.
Unlike traditional pharmacy websites, TrumpRx.gov does not sell medications directly. Users can either access manufacturer websites for discounted purchases or download coupons for use at local pharmacies. Discounts range widely, including 33% off Pfizer’s Xeljanz for autoimmune disorders and up to 93% off Cetrotide, a fertility treatment by EMD Serono. Some discounts are restricted to individuals facing financial hardship, while others align with deals already offered by platforms like GoodRx, which is listed as an integration partner for the program.
There are, however, significant limitations. TrumpRx discounts apply only to brand-name medications purchased out-of-pocket, excluding generics and insurance-covered drugs. With roughly 92% of Americans insured through private or government plans, co-pays may remain lower than TrumpRx cash prices for many patients. Additionally, spending via TrumpRx may not contribute to insurance deductibles or out-of-pocket maximums. In some cases, cheaper generics are available through other discount platforms; for example, Protonix is listed at $200 on TrumpRx, whereas its generic equivalent, pantoprazole, costs $30 with a coupon from GoodRx.
At launch, TrumpRx features 43 medications from five pharmaceutical companies: AstraZeneca, Eli Lilly, EMD Serono, Novo Nordisk, and Pfizer. The White House has indicated that 11 additional manufacturers will soon join the program. Medications currently available cover multiple categories, including diabetes and metabolic disorders (Farxiga, Insulin Lispro, Ozempic, Wegovy, Xigduo XR, Zepbound), thyroid and adrenal conditions (Cortef, Cytomel, Levoxyl), growth hormone therapies (Genotropin, Ngenla), cardiovascular treatments (Colestid, Lopid), respiratory drugs (Airsupra, Bevespi), psychiatric and neurologic treatments (Pristiq, Chantix, Zarontin), antibiotics and antifungals (Cleocin, Diflucan, Vfend, Zyvox), antivirals (Viracept), gastrointestinal medications (Protonix), immunology and inflammatory drugs (Abrilada, Xeljanz, Medrol), dermatology treatments (Eucrisa), rheumatology drugs (Azulfidine, Azulfidine EN), urology medications (Toviaz), women’s health and hormonal therapies (Duavee, Premarin, Prempro, Estring), fertility treatments (Cetrotide, Gonal F, Ovidrel), smoking cessation (Nicotrol), migraine treatment (Zavzpret), and cardiac rhythm medications.
While TrumpRx may not drastically reduce costs for all Americans, it creates an additional option for those paying out-of-pocket and for medications not fully covered by insurance. Millions of consumers without coverage, or facing high-cost specialty drugs, can compare discounts across TrumpRx, GoodRx, Mark Cuban’s CostPlus Drugs, and other platforms to find the most economical solution.
Earlier we wrote that IRS Announces Expected Timeline for 2025 Tax Refunds, Direct Deposits Likely by March 2